Evolution of Acquired Drug Resistance in BRAF-Mutant Melanoma

Evolution of Acquired Drug Resistance in BRAF-Mutant Melanoma

Melanoma is a highly aggressive type of skin cancer. Metastatic melanoma tumors have historically featured a particularly poor prognosis and have often been considered incurable. Recent advances in targeted therapeutic interventions have radically changed the landscape in metastatic melanoma managem...

Full description

Saved in:
Bibliographic Details
Main Authors: Josué Ballesteros-Álvarez, Ana M. Blázquez-Medela
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:DNA
Subjects:
melanoma
drug resistance
mutation
tumor clonal evolution
BRAF
MITF
Online Access:https://www.mdpi.com/2673-8856/4/4/25
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items